Evidence map›Paper›PMID 36965300›Full record

ArticleComputer methods and programs in biomedicine2023

CVD22: Explainable artificial intelligence determination of the relationship of troponin to D-Dimer, mortality, and CK-MB in COVID-19 patients.

Kevser Kübra Kırboğa, Ecir Uğur Küçüksille, Muhammet Emin Naldan, Mesut Işık, Oktay Gülcü, Emrah Aksakal

Abstract read
In one paragraph

Article in Computer methods and programs in biomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kevser Kübra KırboğaBilecik Seyh Edebali University, Bioengineering Department, 11230, Bilecik, Turkey; Informatics Institute, Istanbul Technical University, Maslak, Istanbul, 34469, Turkey. Electronic address: kubra.kirboga@yahoo.com.
Ecir Uğur KüçüksilleSüleyman Demirel University, Engineering Faculty, Department of Computer Engineering, Isparta 32260, Turkey.
Muhammet Emin NaldanBilecik Seyh Edebali University, Faculty of Medicine, Department of Anaesthesiology and Reanimation, 11230, Bilecik, Turkey.
Mesut IşıkBilecik Seyh Edebali University, Bioengineering Department, 11230, Bilecik, Turkey.
Oktay GülcüHealth Sciences University, Erzurum City Hospital, Department of Cardiology, Erzurum, Turkey.
Emrah AksakalHealth Sciences University, Erzurum City Hospital, Department of Cardiology, Erzurum, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeCOVID-19, which emerged in Wuhan (China), is one of the deadliest and fastest-spreading pandemics as of the end of 2019. According to the World Health Organization (WHO), there are more than 100 million infectious cases worldwide. Therefore, research models are crucial for managing the pandemic scenario. However, because the behavior of this epidemic is so complex and difficult to understand, an effective model must not only produce accurate predictive results but must also have a clear explanation that enables human experts to act proactively. For this reason, an innovative study has been planned to diagnose Troponin levels in the COVID-19 process with explainable white box algorithms to reach a clear explanation.

methodsUsing the pandemic data provided by Erzurum Training and Research Hospital (decision number: 2022/13-145), an interpretable explanation of Troponin data was provided in the COVID-19 process with SHApley Additive exPlanations (SHAP) algorithms. Five machine learning (ML) algorithms were developed. Model performances were determined based on training, test accuracies, precision, F1-score, recall, and AUC (Area Under the Curve) values. Feature importance was estimated according to Shapley values by applying the SHApley Additive exPlanations (SHAP) method to the model with high accuracy. The model created with Streamlit v.3.9 was integrated into the interface with the name CVD22.

resultsAmong the five-machine learning (ML) models created with pandemic data, the best model was selected with the values of 1.0, 0.83, 0.86, 0.83, 0.80, and 0.91 in train and test accuracy, precision, F1-score, recall, and AUC values, respectively. As a result of feature selection and SHApley Additive exPlanations (SHAP) algorithms applied to the XGBoost model, it was determined that DDimer mean, mortality, CKMB (creatine kinase myocardial band), and Glucose were the features with the highest importance over the model estimation.

conclusionsRecent advances in new explainable artificial intelligence (XAI) models have successfully made it possible to predict the future using large historical datasets. Therefore, throughout the ongoing pandemic, CVD22 (https://cvd22covid.streamlitapp.com/) can be used as a guide to help authorities or medical professionals make the best decisions quickly.

Indexed as

Artificial IntelligenceCOVID-19AlgorithmsFibrin Fibrinogen Degradation ProductsHumansFibrin Fibrinogen Degradation Productsfibrin fragment DCoronavirus, TroponinCOVID-19creatine kinaseexplainable artificial intelligence

Identifiers

PMID36965300
PMCPMC10023204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.